• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493919938300
Device Problem Occlusion Within Device (1423)
Patient Problems Myocardial Infarction (1969); Reocclusion (1985); ST Segment Elevation (2059)
Event Date 01/05/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.A review of the manufacturing documentation found that all devices shipped from the batch conformed to the preventive measures / current controls.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
(b)(6).It was reported that in-stent restenosis (isr) occurred.In (b)(6) 2013, clinical status assessment indicated the patient's qualifying condition was unstable angina.Cardiac catheterization was recommended.Subsequently, the index procedure was performed.The target lesion was located from proximal left anterior descending (lad) artery extending up to mid lad with 90% stenosis and was 24mm long with a reference vessel diameter of 3.0mm.The target lesion was treated with pre-dilatation and placement of a 38x3.00mm study stent and residual stenosis was 0% (timi flow 3).In (b)(6) 2013, the patient was discharged on dual antiplatelet therapy.In (b)(6) 2017, the patient was diagnosed with acute myocardial infarction/non st elevation mi (nstemi) and was hospitalized on the same day.The troponin i levels were elevated to 0.094 ng/ml.Cardiac catheterization revealed high grade isr with moderate stenosis at the proximal portion of the study stent.On the same day, isr in mid lad was treated with placement of two drug-eluting stents (des) (3.0x15mm and 3.25x12mm) with the residual stenosis was 0% (timi flow 3).Additionally, on the same day, percutaneous coronary intervention (pci) of proximal right coronary artery was treated with placement of 3.0x28mm des with the residual stenosis was 0% (timi flow 3).The following day, the patient was discharged from the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6888971
MDR Text Key87176247
Report Number2134265-2017-09199
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/28/2013
Device Model NumberH7493919938300
Device Lot Number15714695
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/29/2017
Initial Date FDA Received09/22/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/13/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
-
-